226 related articles for article (PubMed ID: 28964445)
1. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
[TBL] [Abstract][Full Text] [Related]
2. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
5. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
Shafie AA; Lim YW; Chua GN; Hassali MA
Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
7. Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran.
Lankarani KB; Ghahramani S; Moradi N; Shahraki HR; Lotfi F; Honarvar B
Appl Health Econ Health Policy; 2018 Dec; 16(6):837-846. PubMed ID: 30123949
[TBL] [Abstract][Full Text] [Related]
8. Willingness to pay for voluntary community-based health insurance: findings from an exploratory study in the state of Penang, Malaysia.
Shafie AA; Hassali MA
Soc Sci Med; 2013 Nov; 96():272-6. PubMed ID: 23528670
[TBL] [Abstract][Full Text] [Related]
9. Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Med Care; 2011 Mar; 49(3):267-72. PubMed ID: 21224742
[TBL] [Abstract][Full Text] [Related]
10. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
11. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
Byrne MM; O'malley K; Suarez-Almazor ME
Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
[TBL] [Abstract][Full Text] [Related]
13. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
14. An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran.
Moradi N; Woldemichael A; Malekian P; Rotvandi DM; Rezaei S
Cost Eff Resour Alloc; 2020; 18():47. PubMed ID: 33110399
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A; Goto R; Yoneyama-Hirozane M
J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
[No Abstract] [Full Text] [Related]
16. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
17. WILLINGNESS TO PAY FOR LUNG CANCER TREATMENT: PATIENT VERSUS GENERAL PUBLIC VALUES.
Thongprasert S; Crawford B; Sakulbumrungsil R; Chaiyakunapruk N; Petcharapiruch S; Leartsakulpanitch J; Permsuwan U
Int J Technol Assess Health Care; 2015 Jan; 31(4):264-70. PubMed ID: 26353902
[TBL] [Abstract][Full Text] [Related]
18. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
19. Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia.
Tan RTH; Abdul Rasid SZ; Wan Ismail WK; Tobechan J; Tan ETY; Yusof AN; Low JH
Appl Health Econ Health Policy; 2022 Mar; 20(2):255-267. PubMed ID: 34927225
[TBL] [Abstract][Full Text] [Related]
20. Estimating a constant WTP for a QALY-a mission impossible?
Sund B; Svensson M
Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]